Advanced age raises mortality risk in metastatic prostate cancer. Learn how PSA, tumour grade, and treatment influence ...
Patients with cardiovascular-kidney-metabolic syndrome, especially those in the advanced stages at baseline, show a ...
The launch of Nigeria’s National Cancer Control Plan is more than a policy update; it signals a fundamental shift in how the country confronts cancer. For too long, cancer care in Nigeria has been ...
TLX597-Tx is a PSMA1-targeting small molecule radioligand therapy (RLT) candidate, designed to improve quality-of-life and efficacy in ...
Celcuity (CELC) cautious Buy: gedatolisib upside hinges on Q2 2026 mutant cohort data in 2L HR+/HER2- breast cancer.
EVERSANA, a purpose-built, partner-led commercial organization, positions Candel for potential U.S. commercial launch following planned BLA ...
Survivors have a heightened risk of developing cardiovascular disease, pain, insomnia, psychosocial distress and new cancers.
For the first time since last July the FDA's Oncologic Drugs Advisory Committee (ODAC) will meet on Thursday to evaluate two ...
Prostate cancer represents one of the most common malignancies in men in developed countries with increasing incidence in recent years due to the ...
The National Comprehensive Cancer Network® (NCCN®)-an alliance of leading cancer centers-has published a new book explaining ...
Researchers at the University of British Columbia and BC Cancer have developed a new way to target proteins long considered ...
Nuclear medicine is being called a new frontier in cancer care, and new research shows potential new uses for it in treating ...